Molina Healthcare (MOH) outlines 2026 Investor Day webcast and materials
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Molina Healthcare, Inc. filed a current report stating it is hosting an Investor Day conference on May 8, 2026, beginning at 9:30 a.m. Eastern Time. During the event, the company plans to share updates on its business, including long-term financial targets and strategic and operational plans.
The presentation used for Investor Day is provided as Exhibit 99.1 and is incorporated by reference. A live webcast and a 30-day online replay of the event will be available on the company’s investor relations website.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Investor Day date: May 8, 2026
Start time: 9:30 a.m. Eastern Time
Replay period: 30-day online replay
3 metrics
Investor Day date
May 8, 2026
Date of Molina Healthcare’s Investor Day conference
Start time
9:30 a.m. Eastern Time
Start time of the Investor Day webcast
Replay period
30-day online replay
Length of time replay is available on investor site
Key Terms
Regulation FD Disclosure, Investor Day Conference, Inline XBRL, Investor relations website
4 terms
Regulation FD Disclosure regulatory
"Item 7.01. Regulation FD Disclosure."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
Investor Day Conference financial
"will host its Investor Day Conference on May 8, 2026"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Investor relations website financial
"A live webcast ... will be accessible on the Company’s investor relations website"
An investor relations website is a company's online page where it shares important information with current and potential investors, like financial results, company news, and future plans. It’s like a company’s official report card that helps people understand how the business is doing and decide whether to invest or stay informed.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 8, 2026
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code) |
Registrant’s telephone number, including area code: (562 ) 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
☐ |
Item 7.01. Regulation FD Disclosure.
As previously announced, Molina Healthcare, Inc. (the “Company”) will host its Investor Day Conference on May 8, 2026, beginning at 9:30 a.m. Eastern Time. At the event, the Company will provide various updates regarding its business, including on its long-term financial targets and strategic and operational plans. A copy of the Investor Day presentation materials is attached hereto as Exhibit 99.1 and incorporated herein by reference.
A live webcast of the Company’s Investor Day will be accessible on the Company’s investor relations website at investors.molinahealthcare.com. Instructions for accessing the webcast can be found on the Company’s investor relations website. A 30-day online replay of the Investor Day meeting will be available on the Company’s investor relations website shortly following the conclusion of the live webcast. The information contained in such website is not part of this Form 8-K.
Note: The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
The Company’s Investor Day presentation and accompanying oral remarks include numerous forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this Form 8-K may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements include, but are not limited to, statements regarding our 2029 performance outlook, our 2029 premium revenue, and our 2029 adjusted EPS targets; medical cost trends; Medicaid, Medicare, and Marketplace rates; legislative and regulatory changes and impacts; our projected growth, including RFP and M&A opportunities; our implementation of the Florida Children’s Medical Services program contract; our implementation of artificial intelligence initiatives and expected capabilities; our general and administrative expenses; our embedded earnings and their realization; our capital deployment; our guidance for the balance of fiscal year 2026; and our premium outlook for fiscal year 2027.
Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings, “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the period ended March 31, 2026.
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this Form 8-K represent the Company’s judgment as of May 8, 2026, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.
Item 9.01. Financial Statements and Exhibits.
|
(d)
|
Exhibits:
|
|
Exhibit
No.
|
Description
|
|
99.1
|
Molina Healthcare, Inc. 2026 Investor Day Presentation, dated May 8, 2026.
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MOLINA HEALTHCARE, INC. | |||
|
|
|
||
| Date: May 8, 2026 |
By:
|
/s/ Jeff D. Barlow
|
|
|
|
Jeff D. Barlow,
|
||
|
|
Chief Legal Officer and Secretary
|
Exhibit 99.1
FAQ
What did Molina Healthcare (MOH) disclose in this 8-K filing?
Molina Healthcare disclosed it is hosting an Investor Day conference on May 8, 2026, to provide updates on its business, long-term financial targets, and strategic and operational plans, with materials furnished as Exhibit 99.1.
When is Molina Healthcare (MOH) holding its 2026 Investor Day?
Molina Healthcare is holding its 2026 Investor Day on May 8, 2026, starting at 9:30 a.m. Eastern Time. The event will cover business updates, long-term financial targets, and strategic and operational plans for the company.
How can investors access Molina Healthcare’s 2026 Investor Day webcast?
Investors can access the live webcast through Molina Healthcare’s investor relations website at investors.molinahealthcare.com. Instructions for accessing the webcast are provided on the site, and the company will host a 30-day replay after the event.
Will a replay of Molina Healthcare (MOH) 2026 Investor Day be available?
Yes, a 30-day online replay of Molina Healthcare’s 2026 Investor Day will be available on its investor relations website shortly after the live webcast concludes, allowing investors to review the company’s presentations and business updates.
What is Exhibit 99.1 in Molina Healthcare’s May 8, 2026 filing?
Exhibit 99.1 is the Molina Healthcare, Inc. 2026 Investor Day Presentation dated May 8, 2026. It contains the materials used at the Investor Day conference and is incorporated by reference into the current report.
What regulation item does this Molina Healthcare (MOH) 8-K relate to?
This 8-K relates to Item 7.01, Regulation FD Disclosure. It furnishes information about Molina Healthcare’s Investor Day event, including business updates, financial targets, and related presentation materials, ensuring fair disclosure to the market.